Acceleron Pharma (NASDAQ:XLRN) Rating Reiterated by Zacks Investment Research – Mayfield Recorder
Acceleron Pharma (NASDAQ:XLRN) Rating Reiterated by Zacks Investment Research Mayfield Recorder
Acceleron Pharma (NASDAQ:XLRN)’s stock had its “hold” rating reiterated by Zacks Investment Research in a research report issued to clients and investors on …
Source: Investment New Feed